US20220346702A1 - Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections - Google Patents
Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections Download PDFInfo
- Publication number
- US20220346702A1 US20220346702A1 US17/682,839 US202217682839A US2022346702A1 US 20220346702 A1 US20220346702 A1 US 20220346702A1 US 202217682839 A US202217682839 A US 202217682839A US 2022346702 A1 US2022346702 A1 US 2022346702A1
- Authority
- US
- United States
- Prior art keywords
- patient
- cosmetic agent
- skin
- photographs
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 87
- 239000002537 cosmetic Substances 0.000 title claims abstract description 46
- 238000002347 injection Methods 0.000 title claims description 31
- 239000007924 injection Substances 0.000 title claims description 31
- 238000011282 treatment Methods 0.000 title description 34
- 201000001119 neuropathy Diseases 0.000 title description 6
- 230000007823 neuropathy Effects 0.000 title description 6
- 230000008685 targeting Effects 0.000 title 1
- 238000012544 monitoring process Methods 0.000 claims abstract description 7
- 238000004458 analytical method Methods 0.000 claims description 43
- 210000003205 muscle Anatomy 0.000 claims description 37
- 206010033799 Paralysis Diseases 0.000 claims description 24
- 230000033001 locomotion Effects 0.000 claims description 23
- 239000013598 vector Substances 0.000 claims description 23
- 238000006073 displacement reaction Methods 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 19
- 239000011148 porous material Substances 0.000 claims description 19
- 230000009471 action Effects 0.000 claims description 18
- 210000001061 forehead Anatomy 0.000 claims description 16
- 108030001720 Bontoxilysin Proteins 0.000 claims description 12
- 229940053031 botulinum toxin Drugs 0.000 claims description 12
- 206010040954 Skin wrinkling Diseases 0.000 claims description 6
- 108010057266 Type A Botulinum Toxins Proteins 0.000 claims description 3
- 229940094657 botulinum toxin type a Drugs 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 230000004118 muscle contraction Effects 0.000 description 15
- 101710117542 Botulinum neurotoxin type A Proteins 0.000 description 13
- 229940089093 botox Drugs 0.000 description 13
- 208000004064 acoustic neuroma Diseases 0.000 description 11
- 208000014070 Vestibular schwannoma Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 238000011084 recovery Methods 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 210000004709 eyebrow Anatomy 0.000 description 8
- 210000001097 facial muscle Anatomy 0.000 description 8
- 210000005036 nerve Anatomy 0.000 description 8
- 230000035882 stress Effects 0.000 description 8
- 230000008602 contraction Effects 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 230000003387 muscular Effects 0.000 description 5
- 208000005890 Neuroma Diseases 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 102000007517 Neurofibromin 2 Human genes 0.000 description 3
- 108010085839 Neurofibromin 2 Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000004397 blinking Effects 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 210000000887 face Anatomy 0.000 description 3
- 208000002761 neurofibromatosis 2 Diseases 0.000 description 3
- 208000022032 neurofibromatosis type 2 Diseases 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 206010047571 Visual impairment Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 241000282412 Homo Species 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 241000225674 Procerus Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/442—Evaluating skin mechanical properties, e.g. elasticity, hardness, texture, wrinkle assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1107—Measuring contraction of parts of the body, e.g. organ, muscle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1126—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb using a particular sensing technique
- A61B5/1128—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb using a particular sensing technique using image analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
- A61B5/4041—Evaluating nerves condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
Definitions
- the present invention relates to both cosmetic treatments and to more serious conditions, including neuropathies (e.g., those caused by an acoustic neuroma) and stroke. More specifically, the invention relates to methods of optimizing where cosmetic agents such as botulinum toxin are best applied (e.g., injected); to methods of determining when and where treatment, including surgical intervention, for neuropathies should be undertaken; and to methods of evaluating the extent to which a patient's condition is improving or declining (e.g., as a neuropathy develops or during or after a stroke).
- cosmetic agents such as botulinum toxin are best applied (e.g., injected)
- methods of determining when and where treatment, including surgical intervention, for neuropathies should be undertaken e.g., a neuropathy develops or during or after a stroke.
- Digital Image Speckle Correlation (DISC) analysis is a sensitive, non-invasive technique that calculates the magnitude and vector of muscle contraction through photographic analysis.
- This technique has been used in animal studies of skin dynamics (see, e.g., Guan et al., Dermatol. 208(2):112-119, 2004).
- the technique has been used to characterize the biomechanical properties of human skin and to assess the effects of aging.
- U.S. Patent Application No. 2007/0125390 describes methods of evaluating structural changes in the skin due to exogenous or endogenous factors. More specifically, U.S. Patent Application No.
- 2009/0022665 describes methods employing DISC analysis for evaluating immediate effect skin-molding agents, which are topically applied agents that cause a measurable, quantifiable change and/or reaction in the skin. Images are obtained before and after applying such agents in order to evaluate the skin's reaction and thereby determine the desirability of the agent. As noted therein, the methods provide for evaluating the skin's response to cosmetic, dermatologic or medicinal treatment or to any other factor alleged to affect the skin.
- the present invention is based on our conception of methods for extending DISC to direct clinical application.
- the methods are based on following the deformation of a set of speckles (e.g., a correlated set of speckles), whose density defines the spatial resolution (denser speckles providing greater spatial resolution).
- speckles e.g., a correlated set of speckles
- density defines the spatial resolution (denser speckles providing greater spatial resolution).
- speckle material can be used
- the pores intrinsic to the skin form an ideal set of features that can also be followed.
- any of the methods of the invention can employ extrinsic speckle material and/or intrinsic pores or other skin surface markers (e.g., the stubble of a beard).
- the present methods can be carried out by analyzing natural motions, such as one or more of the following, to generate skin deformation: smiling (e.g., slight smiling), eye movement (e.g., blinking or looking in a defined direction), movement of the jaw, lips, or tongue (e.g., opening of the mouth), and movement of the forehead (e.g., raising one or both eyebrows and frowning).
- smiling e.g., slight smiling
- eye movement e.g., blinking or looking in a defined direction
- movement of the jaw, lips, or tongue e.g., opening of the mouth
- movement of the forehead e.g., raising one or both eyebrows and frowning
- the vector displacement of the skin generated by DISC or DISC-like analysis can further be used to calculate the magnitude and direction of muscle contraction.
- non-cosmetic conditions or procedures are contemplated (e.g., an acoustic neuroma or following a stroke (whether pharmaceutically treated and/or treated with physical therapy).
- DISC a change in nerve function of 12 patients suffering from acoustic neuroma.
- Another study was done to quantify the effects of botulinum toxin Type A (BOTOX®) on tension and contraction of treated muscle groups in six patients for a period of six months.
- BOTOX® botulinum toxin Type A
- many invasive techniques which can be painful, have been used to see the effect of acoustic neuroma on nerve function.
- past treatment was based on subjective measures of aesthetic outcomes.
- DISC as a sensitive non-invasive tool that derives corresponding displacement vectors through tracking geometric features on digital images before and after muscle deformation (e.g., before and after a patient is asked to assume a particular pose, such as smiling).
- images e.g., digitized images
- DISC analysis can improve the current standard of care for cosmetic treatments in which an agent that alters the muscular function or form of the face is injected.
- neuropathies including acoustic neuromas
- the present methods can be adopted to analyze the extent of a stroke and/or a patient's recovery.
- the methods of the present invention are not limited to those (and can exclude those) in which the skin's response to cosmetic, dermatologic or medicinal treatment is evaluated following treatment.
- the present methods can be employed prior to treatment in order to inform the application of the treatment, for example, to optimize the treatment (e.g., by selecting a targeted area for treatment and/or determining the number and or size of an area or areas to be treated).
- the methods can also be applied both before and after the treatment; they are not merely evaluative. As indicated for neuromas, the present methods can help the treating physician or surgeon determine the effect of the neuroma on nerve function and treat the patient accordingly. The same is true in the event of stroke. Any of the methods of the invention can include a step of selecting or identifying a patient who will or who may benefit from treatment. As acoustic neuromas have been linked with the genetic disorder neurofibromatosis type 2 (NF2), the present methods focused on neuropathies can include a step of identifying a patient suffering from NF2. In addition, the methods can be employed over time to monitor the progress of a condition or the progress of recovery following nerve repair and/or muscular injection.
- NF2 neurofibromatosis type 2
- the invention is not limited to methods in which DISC, as strictly and currently understood, is applied.
- the present methods can be carried out using any technique that calculates the magnitude and direction (vector) of muscle contraction in a sufficiently sensitive manner. While photographic analysis is inexpensive and convenient, other imaging techniques that allow muscle contraction to be analyzed by DISC or a DISC-like technique can also be used.
- FIG. 1 is an outline of the photographic process and analysis for patients who wish to undergo a cosmetic procedure (e.g., BOTOX® injections) and patients with an acoustic neuroma.
- a cosmetic procedure e.g., BOTOX® injections
- FIG. 2 includes a series of color maps produced by DISC analysis, a bar graph summarizing the data, and a representative photograph of a patient.
- the data in the color maps is much easier to discern from color photographs, one can see, even from the black and white copies shown here, the evidence of muscle contraction at “0 Day” when the patient is frowning (prior to BOTOX® injection), the lack of contraction due to muscle paralysis at “Week 1” and “Week 2”, and the gradual return of muscle contraction over the subsequent periods of time when the patient frowns.
- FIG. 3 is a series of contour maps produced by DISC analysis, with the length and direction of the arrows indicating the magnitude and direction of muscle tension generated in a patient who was photographed while frowning.
- the contour maps were generated at the times shown (i.e., at “0 day” (upper left) and then at 1, 2, and 4 weeks after BOTOX® injection (moving from left to right across the top row of contour maps); photographs taken at later times, as labeled, are shown in the second and third rows).
- FIG. 4 shows a photograph of a patient performing another facial movement, raising her eyebrows rather than frowning, and a corresponding contour graph.
- One of ordinary skill in the art could overlap the photograph with the contour map to determine the location of areas of stress.
- FIG. 5 includes a series of color maps generated from photographs obtained on “0 Day”—before a patient received a BOTOX® injection—and 1, 2, 4, and 8 weeks afterward. Even though the black-and-white reproductions of the color figures are not as informative, one can still see the reduction in muscle contraction after the BOTOX® injection and its reemergence over time.
- FIG. 5 also includes a bar graph plotting the average degree of deformation over time.
- FIG. 6 includes a photograph of a patient diagnosed as having an acoustic neuroma. This patient has already undergone surgical treatment, and the data shown in the contour and color maps are used to assess the degree of asymmetry of muscular activity (the color map on the left depicts motion along the X axis and the color map on the right depicts motion along the Y axis).
- FIG. 7 includes a photograph of a patient diagnosed as having an acoustic neuroma. This patient has not undergone surgical treatment, and greater asymmetry in muscular ability relative to the treated patient assessed in FIG. 6 is evident in the contour and color maps generated from photographs using DISC analysis.
- the present methods are based, in part, on our recognition that DISC analysis can be used to monitor enervation of muscles (e.g., facial muscles) and to monitor skin mechanics and the stress or tension on the skin from underlying muscles (e.g., facial muscles).
- muscles e.g., facial muscles
- DISC is likely to be both less expensive and easier. We expect it will also provide detailed information about muscle paralysis, tension, and contraction.
- DISC in the context of BOTOX® injections, we expect DISC to be useful in quantifying the initial paralysis of each treated muscle group (e.g., in the forehead, glabellar complex, and around the eyes) and in revealing differences in the response to treatment among the muscle groups, including the rate of return-of-function over time.
- Another expected advantage of the present methods is that, while the data obtained may reveal certain general constants, they also provide highly individualized or “personal” treatments.
- DISC analysis enhances or supplements visual, clinical judgment by providing indicators of where the BOTOX® injections should be made to produce optimal cosmetic results.
- FIG. 1 shows that patients who are contemplating BOTOX® injections would be photographed at least twice; once with their faces at rest and once while making a small movement (e.g., raising their eyebrows to generate muscle contraction in the forehead; frowning to contract the muscles in the glabellar complex, between the eyebrows; or blinking to generate muscle contraction in the area where “crow's feet” typically develop).
- the paired images e.g., photographs; resting and non-resting
- can be taken over time e.g., prior to BOTOX® injection, at about 1 week, 2 weeks, 4 weeks, and monthly for up to about six months following the injection(s)).
- the digital photographs obtained can be analyzed using DISC analysis, and facial muscle contraction can be quantified and compared to baseline. If desired, the quantitative analysis can be corroborated with FLO-11®, SPA®, Measure, and SGA (physician and patient) scores.
- FIG. 1 also shows that patients who have been diagnosed with an acoustic neuroma can similarly be photographed with their faces at rest and while making a movement (e.g., a small movement).
- the photographs can be taken at points in time (e.g., approximately weekly, monthly, or quarterly) to monitor the progression of the neuroma prior to treatment or at points in time (e.g., approximately weekly, monthly, or quarterly) to monitor the patient's progress or recovery after treatment (e.g., surgical intervention for the neuroma).
- DISC analysis is used to analyze the digital photographs.
- the system can include a camera for capturing digital images (preferably providing a minimum of four mega pixel resolution). This resolution is sufficient to resolve the pores of human skin, which can be the cutaneous points being tracked in the methods of the present invention. While virtually any feature in the image field may be used to track between images, successful DISC-type techniques depend on a plurality of features to track. As noted above, in humans, skin pores fulfill this requirement.
- Some useful cameras are Canon EOS Rebel Digital camera (6.3 mega pixel resolution), the Toshiba DK-120F CCD camera, the five-mega pixel Canon D60 or Canon Powershot Prol. Data collected by the camera can be pre-processed by a frame grabber, such as PIXCI® from EPIX®, and the digitized information is downloaded to a computer for numerical analysis.
- a frame grabber such as PIXCI® from EPIX®
- Other research groups have developed their own software on the DISC technique to suit their own needs; thus, there is room for customization and such modifications and adaptations are within the skill of one of ordinary skill in the art. Persons of ordinary skill in the art are capable of developing such software without undue burden.
- the methods comprise capturing two or more images of the subject.
- a procedure with just two images is described, and easily extended to more than two images.
- a first image of a surface i.e. a portion of skin
- a second image of the surface can be made when the patient has generated some movement (e.g., by performing a grin or slight smile; in the event of a neurological impairment, the movement will obviously vary depending on the patient's ability to achieve the desired muscle control).
- the area of the patient's body being imaged can be partially immobilized. For example, where the area of study is on the face, a chin rest or other device may be used to help hold a subject's head still. Useful devices of this type are available from Canfield Scientific. It is also preferable that the camera (or other image capture device) be held still during use.
- software such as Photoshop from Adobe®
- software can be employed once an image has been obtained.
- such software can be used to impose on the images a boundary of the area to be studied and a reference coordinate system.
- the software can also be used for obtaining a rough estimate of pore displacement.
- the boundaries can be somewhat arbitrary and may be chosen to define a domain large enough for analyzing several areas of the skin.
- More sophisticated image analysis software is commercially available. For example, products sold under the OriginLab® label are able to analyze DISC-type digital image data to calculate values for a host of mechanical properties of the material under investigation.
- the image analysis software determines the coordinates of each pore in the displacement field relative to the reference coordinate system, for the before and after image. From this data, correlations are established between the pores in the before and after images and a field of displacement vectors, as discussed above, may be generated.
- Each displacement vector represents the movement of one pore from its initial to final location.
- Each pore vector in the field of displacement vectors is resolved into its vertical and horizontal projections, from which vertical and/or horizontal projection maps may be produced. In the projection maps, the horizontal and vertical axes convey the coordinates of any position in the field of study. Areas of constant displacement are color coded in these figures.
- the invention features methods, which we may also refer to as techniques (e.g., a non-invasive technique) for assessing nerve function in the skin.
- the methods can include the step of obtaining an image of the patient (e.g., photographing a patient) suspected of having compromised nerve function.
- the images e.g., photographs
- the images can be taken of one or more areas of the patient's skin while the patient is at rest and then taken again while the patient is performing an action.
- the images (e.g., photographs) are then subjected to DISC or DISC-like analysis.
- the patient can be suspected of having an acoustic neuroma, and the one or more areas of the patient's skin that are imaged can be areas of skin on the patient's face or neck.
- the skin can also be located on one or more of the chest, back, arm, leg, hand or foot.
- the patient may have been instructed to perform one or more of the following movements: moving the jaw, lips, or tongue; moving the eyes; or moving the forehead.
- the DISC or DISC-like analysis can be performed on two or more occasions in time in order to assess the stability or instability of the nerve function.
- the DISC analysis per se can include a step of quantifying the strength and/or qualifying the direction of the effect produced when the patient is performing an action relative to the patient at rest.
- the DISC analysis can also include the step of examining one or more vector displacement maps of skin markers (e.g., pores).
- the DISC analysis can further include the step of identifying the principle axis of strain in the vector displacement maps.
- the invention features methods or techniques (e.g., non-invasive techniques) for determining where a cosmetic agent that causes muscle paralysis should be injected.
- these methods also include a step of imaging (e.g., photographing) a patient.
- imaging e.g., photographing
- the images e.g., photographs
- the images are taken of one or more areas of the patient's skin while the patient is at rest and again while the patient is performing an action.
- the images are then subjected to DISC or DISC-like analysis.
- These methods can further include a step of generating a vector diagram based on the DISC analysis that indicates the locus of large stress on the skin from muscular tension and a step of injecting the cosmetic agent at the locus of large stress.
- the areas of the patient's skin one would image can include the skin of the face or neck, and the patient may have been instructed to perform one or more of the following movements: moving the jaw, lips, or tongue; moving the eyes; or moving the forehead.
- the DISC analysis per se can include a step of quantifying the strength and/or qualifying the direction (magnitude and direction; vector) of the effect produced when the patient is performing an action relative to the patient at rest.
- the invention features methods or techniques (e.g., non-invasive techniques) for assessing a patient's recovery from stroke.
- the methods can include the step of imaging (e.g., photographing) a patient who has had a stroke.
- the images e.g., photographs
- the images can be taken of one or more areas of the patient's skin covering an area of the body affected by the stroke. For example, an area of the body that is paralyzed to some extent.
- the images are obtained while the patient is at rest and again while the patient is attempting to move the area of the body affected by the stroke, and the images are then subjected to DISC or a DISC-like analysis.
- the one or more areas of the patient's skin can include skin of the face or neck, but may also be skin covering some or all of the chest, back, arms, legs, hands, or feet.
- the patient may be instructed to perform one or more of the following movements: moving the jaw, lips, or tongue; moving the eyes; moving the forehead; or tensing a muscle in the chest, back, arms, legs, hands, or feet.
- the DISC analysis can be performed on two or more occasions in time in order to assess the patient's ability to move the area of the body affected by the stroke as time passes.
- the DISC analysis per se can include quantifying the strength and/or qualifying the direction of the effect produced when the patient is performing an action (or attempting to perform an action) relative to the patient at rest.
- the DISC or DISC-like analysis can also include the step of examining one or more vector displacement maps of skin markers (e.g., pores).
- the steps can include either imaging (e.g., photographing) a patient or providing an image (e.g., a photograph) of a patient.
- the methods can be carried out while a patient is undergoing a treatment in order to help the physician assess the efficacy of the treatment.
- FIGS. 2-7 Examples of data generated from the present methods are shown in FIGS. 2-7 . In addition, the following work has been conducted.
- DISC is based on following the deformation of a correlated set of speckles and generates an essentially complete mapping of the deformation of the skin pores, thereby determining the loci where stress is applied to the skin and the specific combination of muscles involved in a particular motion.
- Botulinum Toxin (BT) has a number of clinical applications, including cosmetic treatment of facial lines.
- BOTOX® the widely used formulation of BT marketed as BOTOX®, however it is to be understood that any cosmetically acceptable agent that similarly induces paralysis could be used and analyzed by the present methods in the same manner.
- the degree and duration of effects on the muscles of facial expression have been evaluated using qualitative subjective measurements (Carruthers and Carruthers, Dermatol.
- the objectives of our study were to quantify the facial muscle paralysis of each treated muscle group (forehead, glabellar complex, and crow's feet) using DISC and to determine the differences in treatment response seen among the muscle groups and the rate of return over time.
- DISC Vector displacement of the skin generated by DISC can help determine the site of injection to produce optimal cosmetic results.
- DISC analysis calculates the magnitude and vector of muscle contraction through photographic analysis and determines the point at which the toxin's effects have fully dissipated by monitoring the return of muscle contraction.
- FIG. 8 Vector diagrams depicting the direction of muscle contraction in the glabellar and forehead region as the patient is subjected to frowning and raising of the eyebrows are also shown in FIG. 8 .
- Such a vector map generated by DISC analysis can give an insight into the areas where stress is directed and how it dissipates following the botulinum toxin treatment. Knowledge of the direction of the muscle contraction can help tailor the site of injection for individual patients.
- DISC analysis can provide insight into the precise duration of muscle paralysis or the cumulative effects of multiple successive treatments. It can enhance clinical judgment, tailoring the amount and location of injections to the unique facial muscle profile of the patient. Additional clinical applications include monitoring the recovery after nerve repair and recording prospective outcomes data for facial transplant recipients. With its highly sensitive, non-invasive nature and ease of reproducibility, we believe DISC analysis can revolutionize outcomes measures in clinical practice.
Abstract
The present invention pertains to methods of determining where, on the skin, a diagnostic, therapeutic, or cosmetic agent is likely to be most effectively applied (e.g., injected), and to methods for monitoring a patient after such an agent has been administered. The monitoring can produce information useful in determining whether a diagnostic, therapeutic (e.g., surgical), or cosmetic regime should be initiated, continued, continued in a modified fashion, or terminated (e.g., for a brief or prolonged period of time). The methods can be repeated periodically and use a non-invasive, in vivo form of digital image speckle correlation (DISC) to track deformation of the skin.
Description
- This application is a continuation of U.S. application Ser. No. 15/944,528, filed Apr. 3, 2018, now U.S. Pat. No. 11,259,740, issuing Mar. 1, 2022, which is a continuation of U.S. application Ser. No. 13/463,766, filed May 3, 2012, abandoned, which claims the benefit of priority to U.S. Application No. 61/482,057, filed May 3, 2011; the contents of each are incorporated herein by reference in their entirety.
- This invention was made with government support under grant number DMR0606387 awarded by the National Science Foundation. The government has certain rights in the invention.
- The present invention relates to both cosmetic treatments and to more serious conditions, including neuropathies (e.g., those caused by an acoustic neuroma) and stroke. More specifically, the invention relates to methods of optimizing where cosmetic agents such as botulinum toxin are best applied (e.g., injected); to methods of determining when and where treatment, including surgical intervention, for neuropathies should be undertaken; and to methods of evaluating the extent to which a patient's condition is improving or declining (e.g., as a neuropathy develops or during or after a stroke).
- Digital Image Speckle Correlation (DISC) analysis is a sensitive, non-invasive technique that calculates the magnitude and vector of muscle contraction through photographic analysis. This technique has been used in animal studies of skin dynamics (see, e.g., Guan et al., Dermatol. 208(2):112-119, 2004). In addition, the technique has been used to characterize the biomechanical properties of human skin and to assess the effects of aging. For example, U.S. Patent Application No. 2007/0125390 describes methods of evaluating structural changes in the skin due to exogenous or endogenous factors. More specifically, U.S. Patent Application No. 2009/0022665 describes methods employing DISC analysis for evaluating immediate effect skin-molding agents, which are topically applied agents that cause a measurable, quantifiable change and/or reaction in the skin. Images are obtained before and after applying such agents in order to evaluate the skin's reaction and thereby determine the desirability of the agent. As noted therein, the methods provide for evaluating the skin's response to cosmetic, dermatologic or medicinal treatment or to any other factor alleged to affect the skin.
- The present invention is based on our conception of methods for extending DISC to direct clinical application. The methods are based on following the deformation of a set of speckles (e.g., a correlated set of speckles), whose density defines the spatial resolution (denser speckles providing greater spatial resolution). While conventional speckle material can be used, the pores intrinsic to the skin form an ideal set of features that can also be followed. Accordingly, any of the methods of the invention can employ extrinsic speckle material and/or intrinsic pores or other skin surface markers (e.g., the stubble of a beard). Instead of an applied force, which is used in traditional mechanical testing, or an invasive technique, the present methods can be carried out by analyzing natural motions, such as one or more of the following, to generate skin deformation: smiling (e.g., slight smiling), eye movement (e.g., blinking or looking in a defined direction), movement of the jaw, lips, or tongue (e.g., opening of the mouth), and movement of the forehead (e.g., raising one or both eyebrows and frowning). One then generates, based on the DISC or DISC-like analysis, a map of the deformation of the speckles or the cutaneous markers (e.g., a pore ensemble), which identifies the loci where stress is applied to the skin, the regions of dissipation of the elastic strain, and the specific combination of muscles involved in a given motion. This allows one to then assess variations in skin elasticity and to map the differences that exist among different regions of, for example, the face, including the area around the eye, the forehead, and the area around the mouth. The vector displacement of the skin generated by DISC or DISC-like analysis can further be used to calculate the magnitude and direction of muscle contraction.
- As noted above, the present methods can be applied where non-cosmetic conditions or procedures are contemplated (e.g., an acoustic neuroma or following a stroke (whether pharmaceutically treated and/or treated with physical therapy). We applied DISC to see a change in nerve function of 12 patients suffering from acoustic neuroma. Another study was done to quantify the effects of botulinum toxin Type A (BOTOX®) on tension and contraction of treated muscle groups in six patients for a period of six months. Previously, many invasive techniques, which can be painful, have been used to see the effect of acoustic neuroma on nerve function. Similarly, for botulinum toxin injections, past treatment was based on subjective measures of aesthetic outcomes. While useful in determining patient satisfaction and self-image following treatment, these metrics fail to objectively quantify the direct effect of botulinum toxin on the facial musculature, nor do they allow us to predict a patient's response to treatment in a meaningful way. The present methods improve upon such outcomes. Despite several validated questionnaires, including the Facial Line Outcome (FLO-11) questionnaire and the Self-Perception of Age (SPA) measure, there is a lack of an objective measurement tool to determine the degree or duration of the toxin's effects (or of any other cosmetic procedure, such as the injection of a filler material to the lips, chin, cheekbones, or forehead). Our methods employ DISC as a sensitive non-invasive tool that derives corresponding displacement vectors through tracking geometric features on digital images before and after muscle deformation (e.g., before and after a patient is asked to assume a particular pose, such as smiling). By taking images (e.g., digitized images), DISC analysis can improve the current standard of care for cosmetic treatments in which an agent that alters the muscular function or form of the face is injected. We expect a similar improvement in the standard of care for neuropathies, including acoustic neuromas, as it can be difficult at present to track the rate of change and determine when to intervene and/or the success of an intervention. Moreover, the present methods can be adopted to analyze the extent of a stroke and/or a patient's recovery. They may be especially useful where the stroke is either mild (making an assessment of the impaired function difficult somewhat difficult to perceive) or major (as function can be so impaired, small degrees of improvement can be difficult to detect). In the case of cosmetic treatments, such as BOTOX® treatments, DISC analysis enhances clinical judgment by indicating where injections should be performed to produce optimal cosmetic results. Thus, the methods of the present invention are not limited to those (and can exclude those) in which the skin's response to cosmetic, dermatologic or medicinal treatment is evaluated following treatment. The present methods can be employed prior to treatment in order to inform the application of the treatment, for example, to optimize the treatment (e.g., by selecting a targeted area for treatment and/or determining the number and or size of an area or areas to be treated). The methods can also be applied both before and after the treatment; they are not merely evaluative. As indicated for neuromas, the present methods can help the treating physician or surgeon determine the effect of the neuroma on nerve function and treat the patient accordingly. The same is true in the event of stroke. Any of the methods of the invention can include a step of selecting or identifying a patient who will or who may benefit from treatment. As acoustic neuromas have been linked with the genetic disorder neurofibromatosis type 2 (NF2), the present methods focused on neuropathies can include a step of identifying a patient suffering from NF2. In addition, the methods can be employed over time to monitor the progress of a condition or the progress of recovery following nerve repair and/or muscular injection.
- Although we tend to stress the use of DISC analysis, the invention is not limited to methods in which DISC, as strictly and currently understood, is applied. The present methods can be carried out using any technique that calculates the magnitude and direction (vector) of muscle contraction in a sufficiently sensitive manner. While photographic analysis is inexpensive and convenient, other imaging techniques that allow muscle contraction to be analyzed by DISC or a DISC-like technique can also be used.
-
FIG. 1 is an outline of the photographic process and analysis for patients who wish to undergo a cosmetic procedure (e.g., BOTOX® injections) and patients with an acoustic neuroma. -
FIG. 2 includes a series of color maps produced by DISC analysis, a bar graph summarizing the data, and a representative photograph of a patient. Although the data in the color maps is much easier to discern from color photographs, one can see, even from the black and white copies shown here, the evidence of muscle contraction at “0 Day” when the patient is frowning (prior to BOTOX® injection), the lack of contraction due to muscle paralysis at “Week 1” and “Week 2”, and the gradual return of muscle contraction over the subsequent periods of time when the patient frowns. -
FIG. 3 is a series of contour maps produced by DISC analysis, with the length and direction of the arrows indicating the magnitude and direction of muscle tension generated in a patient who was photographed while frowning. The contour maps were generated at the times shown (i.e., at “0 day” (upper left) and then at 1, 2, and 4 weeks after BOTOX® injection (moving from left to right across the top row of contour maps); photographs taken at later times, as labeled, are shown in the second and third rows). -
FIG. 4 shows a photograph of a patient performing another facial movement, raising her eyebrows rather than frowning, and a corresponding contour graph. One of ordinary skill in the art could overlap the photograph with the contour map to determine the location of areas of stress. -
FIG. 5 includes a series of color maps generated from photographs obtained on “0 Day”—before a patient received a BOTOX® injection—and 1, 2, 4, and 8 weeks afterward. Even though the black-and-white reproductions of the color figures are not as informative, one can still see the reduction in muscle contraction after the BOTOX® injection and its reemergence over time.FIG. 5 also includes a bar graph plotting the average degree of deformation over time. -
FIG. 6 includes a photograph of a patient diagnosed as having an acoustic neuroma. This patient has already undergone surgical treatment, and the data shown in the contour and color maps are used to assess the degree of asymmetry of muscular activity (the color map on the left depicts motion along the X axis and the color map on the right depicts motion along the Y axis). -
FIG. 7 includes a photograph of a patient diagnosed as having an acoustic neuroma. This patient has not undergone surgical treatment, and greater asymmetry in muscular ability relative to the treated patient assessed inFIG. 6 is evident in the contour and color maps generated from photographs using DISC analysis. - The present methods are based, in part, on our recognition that DISC analysis can be used to monitor enervation of muscles (e.g., facial muscles) and to monitor skin mechanics and the stress or tension on the skin from underlying muscles (e.g., facial muscles). Compared to previously known procedures for monitoring a patient (e.g., over time, either before or after a treatment regimen has been instituted), DISC is likely to be both less expensive and easier. We expect it will also provide detailed information about muscle paralysis, tension, and contraction. Moreover, in the context of BOTOX® injections, we expect DISC to be useful in quantifying the initial paralysis of each treated muscle group (e.g., in the forehead, glabellar complex, and around the eyes) and in revealing differences in the response to treatment among the muscle groups, including the rate of return-of-function over time. Another expected advantage of the present methods is that, while the data obtained may reveal certain general constants, they also provide highly individualized or “personal” treatments. In the context of BOTOX® injections, DISC analysis enhances or supplements visual, clinical judgment by providing indicators of where the BOTOX® injections should be made to produce optimal cosmetic results.
- The outline provided as
FIG. 1 shows that patients who are contemplating BOTOX® injections would be photographed at least twice; once with their faces at rest and once while making a small movement (e.g., raising their eyebrows to generate muscle contraction in the forehead; frowning to contract the muscles in the glabellar complex, between the eyebrows; or blinking to generate muscle contraction in the area where “crow's feet” typically develop). The paired images (e.g., photographs; resting and non-resting) can be taken over time (e.g., prior to BOTOX® injection, at about 1 week, 2 weeks, 4 weeks, and monthly for up to about six months following the injection(s)). The digital photographs obtained can be analyzed using DISC analysis, and facial muscle contraction can be quantified and compared to baseline. If desired, the quantitative analysis can be corroborated with FLO-11®, SPA®, Measure, and SGA (physician and patient) scores. - The outline provided as
FIG. 1 also shows that patients who have been diagnosed with an acoustic neuroma can similarly be photographed with their faces at rest and while making a movement (e.g., a small movement). The photographs can be taken at points in time (e.g., approximately weekly, monthly, or quarterly) to monitor the progression of the neuroma prior to treatment or at points in time (e.g., approximately weekly, monthly, or quarterly) to monitor the patient's progress or recovery after treatment (e.g., surgical intervention for the neuroma). DISC analysis is used to analyze the digital photographs. - A suitable DISC system is described in U.S. Application Publication No. 2007/0125390, and that system and systems like it can be used in the present methods. Thus, as described in the application just mentioned, the system can include a camera for capturing digital images (preferably providing a minimum of four mega pixel resolution). This resolution is sufficient to resolve the pores of human skin, which can be the cutaneous points being tracked in the methods of the present invention. While virtually any feature in the image field may be used to track between images, successful DISC-type techniques depend on a plurality of features to track. As noted above, in humans, skin pores fulfill this requirement. Some useful cameras (as previously described in the application just mentioned) are Canon EOS Rebel Digital camera (6.3 mega pixel resolution), the Toshiba DK-120F CCD camera, the five-mega pixel Canon D60 or Canon Powershot Prol. Data collected by the camera can be pre-processed by a frame grabber, such as PIXCI® from EPIX®, and the digitized information is downloaded to a computer for numerical analysis. Other research groups have developed their own software on the DISC technique to suit their own needs; thus, there is room for customization and such modifications and adaptations are within the skill of one of ordinary skill in the art. Persons of ordinary skill in the art are capable of developing such software without undue burden. Furthermore, there are also commercially available software applications, one being VIC-2D from Correlated Solutions Inc. (West Colombia, S.C.), with an advertised displacement accuracy of better than one one-hundredth of a pixel. Another supplier of digital image correlation systems and software is Optical Metrology Innovations (Cork, Ireland; as noted in the aforementioned U.S. application).
- In one embodiment, the methods comprise capturing two or more images of the subject. A procedure with just two images is described, and easily extended to more than two images. A first image of a surface (i.e. a portion of skin) can be made when the skin and underlying muscles are at rest and a second image of the surface can be made when the patient has generated some movement (e.g., by performing a grin or slight smile; in the event of a neurological impairment, the movement will obviously vary depending on the patient's ability to achieve the desired muscle control). To facilitate the methods, the area of the patient's body being imaged can be partially immobilized. For example, where the area of study is on the face, a chin rest or other device may be used to help hold a subject's head still. Useful devices of this type are available from Canfield Scientific. It is also preferable that the camera (or other image capture device) be held still during use.
- As described in U.S. Application Publication No. 2007/0125390, software, such as Photoshop from Adobe®, can be employed once an image has been obtained. For example, such software can be used to impose on the images a boundary of the area to be studied and a reference coordinate system. The software can also be used for obtaining a rough estimate of pore displacement. As described in the aforementioned application, the boundaries can be somewhat arbitrary and may be chosen to define a domain large enough for analyzing several areas of the skin. More sophisticated image analysis software is commercially available. For example, products sold under the OriginLab® label are able to analyze DISC-type digital image data to calculate values for a host of mechanical properties of the material under investigation. The image analysis software determines the coordinates of each pore in the displacement field relative to the reference coordinate system, for the before and after image. From this data, correlations are established between the pores in the before and after images and a field of displacement vectors, as discussed above, may be generated. Each displacement vector represents the movement of one pore from its initial to final location. Each pore vector in the field of displacement vectors is resolved into its vertical and horizontal projections, from which vertical and/or horizontal projection maps may be produced. In the projection maps, the horizontal and vertical axes convey the coordinates of any position in the field of study. Areas of constant displacement are color coded in these figures. By measuring the displacement of features (pores) at the boundary of the image area, it is, in principle, straightforward to calculate the change in size of the image area. The change in size along the vertical and horizontal directions may be separately calculated, or a total deformation of the image region may be calculated. These may be expressed as percent change in size or strain, induced in the bounded area.
- Alternatively, sufficiently sophisticated digital analysis software is available (i.e. OriginLab®) that can analyze the entire displacement field and directly calculate strain at any position and average strain over the field.
- Accordingly, in one aspect the invention features methods, which we may also refer to as techniques (e.g., a non-invasive technique) for assessing nerve function in the skin. The methods can include the step of obtaining an image of the patient (e.g., photographing a patient) suspected of having compromised nerve function. The images (e.g., photographs) can be taken of one or more areas of the patient's skin while the patient is at rest and then taken again while the patient is performing an action. The images (e.g., photographs) are then subjected to DISC or DISC-like analysis. The patient can be suspected of having an acoustic neuroma, and the one or more areas of the patient's skin that are imaged can be areas of skin on the patient's face or neck. The skin can also be located on one or more of the chest, back, arm, leg, hand or foot. In the “non-rest” or active position, the patient may have been instructed to perform one or more of the following movements: moving the jaw, lips, or tongue; moving the eyes; or moving the forehead. The DISC or DISC-like analysis can be performed on two or more occasions in time in order to assess the stability or instability of the nerve function. The DISC analysis per se can include a step of quantifying the strength and/or qualifying the direction of the effect produced when the patient is performing an action relative to the patient at rest. The DISC analysis can also include the step of examining one or more vector displacement maps of skin markers (e.g., pores). The DISC analysis can further include the step of identifying the principle axis of strain in the vector displacement maps.
- In another aspect, the invention features methods or techniques (e.g., non-invasive techniques) for determining where a cosmetic agent that causes muscle paralysis should be injected. These methods also include a step of imaging (e.g., photographing) a patient. However, these patients are those who wish to be treated with a cosmetic agent. The images (e.g., photographs) are taken of one or more areas of the patient's skin while the patient is at rest and again while the patient is performing an action. The images (e.g., photographs) are then subjected to DISC or DISC-like analysis. These methods can further include a step of generating a vector diagram based on the DISC analysis that indicates the locus of large stress on the skin from muscular tension and a step of injecting the cosmetic agent at the locus of large stress. The areas of the patient's skin one would image can include the skin of the face or neck, and the patient may have been instructed to perform one or more of the following movements: moving the jaw, lips, or tongue; moving the eyes; or moving the forehead. The DISC analysis per se can include a step of quantifying the strength and/or qualifying the direction (magnitude and direction; vector) of the effect produced when the patient is performing an action relative to the patient at rest.
- In another aspect, the invention features methods or techniques (e.g., non-invasive techniques) for assessing a patient's recovery from stroke. The methods can include the step of imaging (e.g., photographing) a patient who has had a stroke. The images (e.g., photographs) can be taken of one or more areas of the patient's skin covering an area of the body affected by the stroke. For example, an area of the body that is paralyzed to some extent. The images are obtained while the patient is at rest and again while the patient is attempting to move the area of the body affected by the stroke, and the images are then subjected to DISC or a DISC-like analysis. The one or more areas of the patient's skin can include skin of the face or neck, but may also be skin covering some or all of the chest, back, arms, legs, hands, or feet. The patient may be instructed to perform one or more of the following movements: moving the jaw, lips, or tongue; moving the eyes; moving the forehead; or tensing a muscle in the chest, back, arms, legs, hands, or feet. The DISC analysis can be performed on two or more occasions in time in order to assess the patient's ability to move the area of the body affected by the stroke as time passes. The DISC analysis per se can include quantifying the strength and/or qualifying the direction of the effect produced when the patient is performing an action (or attempting to perform an action) relative to the patient at rest. The DISC or DISC-like analysis can also include the step of examining one or more vector displacement maps of skin markers (e.g., pores).
- In any of the methods of the invention, the steps can include either imaging (e.g., photographing) a patient or providing an image (e.g., a photograph) of a patient. In the event of a neurological impairment, the methods can be carried out while a patient is undergoing a treatment in order to help the physician assess the efficacy of the treatment.
- Examples of data generated from the present methods are shown in
FIGS. 2-7 . In addition, the following work has been conducted. - As noted above, DISC is based on following the deformation of a correlated set of speckles and generates an essentially complete mapping of the deformation of the skin pores, thereby determining the loci where stress is applied to the skin and the specific combination of muscles involved in a particular motion. Botulinum Toxin (BT) has a number of clinical applications, including cosmetic treatment of facial lines. (In the description above, we have referred to the widely used formulation of BT marketed as BOTOX®, however it is to be understood that any cosmetically acceptable agent that similarly induces paralysis could be used and analyzed by the present methods in the same manner.) Previously, the degree and duration of effects on the muscles of facial expression have been evaluated using qualitative subjective measurements (Carruthers and Carruthers, Dermatol. Surg. 33(1 Spec No.):S10-7, 2007). Here, we successfully quantified the initial facial muscle paralysis as well as monitored the duration of the effect of BT treatment by DISC analysis, a sensitive, non-invasive technique that derives corresponding displacement vectors through tracking geometric features on digital images before and after muscle deformation. This technology has not previously been used in conjunction with BT injection and could provide treating clinicians an insight into optimal dosing and effect duration for individual patients.
- The objectives of our study were to quantify the facial muscle paralysis of each treated muscle group (forehead, glabellar complex, and crow's feet) using DISC and to determine the differences in treatment response seen among the muscle groups and the rate of return over time. Currently, we know of no useful tools to quantify the changes in facial muscle contractile strength following treatment with botulinum toxin. Vector displacement of the skin generated by DISC can help determine the site of injection to produce optimal cosmetic results. DISC analysis calculates the magnitude and vector of muscle contraction through photographic analysis and determines the point at which the toxin's effects have fully dissipated by monitoring the return of muscle contraction.
- In our study protocol, we enrolled male or female patients aged 18 or older (n=6). The patients' photographs were taken pre-treatment with their faces at rest, frowning, raising their eyebrows and blinking to determine the magnitude of baseline reference for muscle motion of individual patients. We then performed injections based on PRS guidelines and physician's subjective muscle mass assessment in the glabellar complex, forehead, and crow's feet. The patients were photographed again immediately following the injections. Follow-up occurred at 1 week, 2 weeks, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, and 24 weeks. Photographs were taken in the same way at these time points, and we performed analysis of the face at each time point in order to monitor changes in muscle contraction over time. For treatment of the glabellar complex (corrugator supercilii, procerus, depressor supercilii, and obicularis oculi), 5-7 injections were given, with males receiving 30-40 units and females receiving 10-30 units. For treatment of crow's feet (orbicularis oculi (lateral part)), 4-10 injections were given (2-5 per side). Males were injected with 6->15 units in total, and females were injected with 6-15 units in total. The results obtained from
Patient 4 while frowning and raising her eyebrows prior to treatment and at specific follow up time points are shown inFIG. 8 . DISC analysis demonstrated substantial facial muscle paralysis beginning at 2 weeks and varying degrees of recovery by 20 weeks, depending upon the individual muscle group. The graphs shown inFIG. 8 demonstrate the paralysis and recovery of the forehead and glabellar areas inPatient 4. The frontalis muscle, which demonstrates a dramatic decrease in contraction when Patient 4 attempts to raise her eyebrows beginning at the second week, also shows a more rapid recovery. The glabellar complex (activated by frowning) also displays a significant drop in contraction strength, with the maximum effect seen at 2 weeks post-treatment, which was greater in magnitude and slower to recover. Despite the demonstrated near recovery of the paralyzed muscles, patient perception of effect only began to decrease slightly at the 12-week time point as measured by FLO-11 (from 90.9 atweek 4 to 74.5 at week 12) and no change in SPA. The DISC results were averaged by Gaussian integration to calculate the percentage change from baseline. - Vector diagrams depicting the direction of muscle contraction in the glabellar and forehead region as the patient is subjected to frowning and raising of the eyebrows are also shown in
FIG. 8 . Such a vector map generated by DISC analysis can give an insight into the areas where stress is directed and how it dissipates following the botulinum toxin treatment. Knowledge of the direction of the muscle contraction can help tailor the site of injection for individual patients. - DISC analysis can provide insight into the precise duration of muscle paralysis or the cumulative effects of multiple successive treatments. It can enhance clinical judgment, tailoring the amount and location of injections to the unique facial muscle profile of the patient. Additional clinical applications include monitoring the recovery after nerve repair and recording prospective outcomes data for facial transplant recipients. With its highly sensitive, non-invasive nature and ease of reproducibility, we believe DISC analysis can revolutionize outcomes measures in clinical practice.
Claims (18)
1. A method for monitoring the effect of one or more injections of a cosmetic agent that induces muscle paralysis, the method comprising:
(a) prior to the one or more injections of a cosmetic agent that induces muscle paralysis, obtaining a baseline degree of deformation in an area to be treated with the cosmetic agent comprising the steps of:
(i) taking one or more photographs of a patient's skin in the area to be treated with the cosmetic agent while the patient is at rest;
(ii) taking one or more photographs of the patient's skin in the area to be treated with the cosmetic agent while the patient is performing an action;
(iii) performing digital image speckle correlation (DISC) analysis on the photographs from steps (a)(i) and (a)(ii), thereby generating a series of displacement vectors that each represents the movement of a pore from its position when the patient is at rest to its position when the patient is performing the action;
(b) after the one or more injections of a cosmetic agent that induces muscle paralysis, obtaining a first degree of deformation in the area treated with the cosmetic agent comprising the steps of:
(i) taking one or more photographs of the patient's skin in the area treated with the cosmetic agent while the patient is at rest;
(ii) taking one or more photographs of the patient's skin in the area treated with the cosmetic agent while the patient is performing the action;
(iii) performing DISC analysis on the photographs from steps (b)(i) and (b)(ii), thereby generating a series of displacement vectors that each represents the movement of a pore from its position when the patient is at rest to its position when the patient is performing the action;
(c) comparing the first degree of deformation from step (b) with the baseline degree of deformation from step (a).
2. The method of claim 1 , further comprising the steps of:
(d) after the one or more injections of a cosmetic agent that induces muscle paralysis, obtaining a second degree of deformation in the area treated with the cosmetic agent comprising the steps of:
(i) taking one or more photographs of the patient's skin in the area treated with the cosmetic agent while the patient is at rest;
(ii) taking one or more photographs of the patient's skin in the area treated with the cosmetic agent while the patient is performing the action;
(iii) performing DISC analysis on the photographs from steps (b)(i) and (b)(ii), thereby generating a series of displacement vectors that each represents the movement of a pore from its position when the patient is at rest to its position when the patient is performing the action;
(e) comparing the degree of deformation from step (d) with the first degree of deformation from step (b) and/or with the baseline degree of deformation from step (a).
3. The method of claim 1 , wherein the area to be treated comprises skin of the face or neck.
4. The method of claim 3 , wherein the area to be treated comprises skin having forehead lines, glabellar lines, or crow's feet.
5. The method of claim 3 , wherein the action performed by the patient comprises smiling; moving the jaw, lips or tongue; moving the eyes; or moving the forehead.
6. The method of claim 1 , wherein the cosmetic agent that induces muscle paralysis comprises botulinum toxin.
7. The method of claim 6 , wherein the cosmetic agent that induces muscle paralysis comprises botulinum toxin type A.
8. The method of claim 1 , wherein steps (b) and (c) are repeated one or more times.
9. The method of claim 1 , wherein step (b) is performed 1 week, 2 weeks, 4 weeks, 8 weeks 12 weeks, 16 weeks, 20 weeks and/or 24 weeks after the one or more injections of a cosmetic agent that induces muscle paralysis.
10. A method for monitoring the effect of one or more injections of a cosmetic agent that induces muscle paralysis, the method comprising:
(a) after the one or more injections of a cosmetic agent that induces muscle paralysis, obtaining a first degree of deformation in an area treated with the cosmetic agent comprising the steps of:
(i) taking one or more photographs of a patient's skin in the area treated with the cosmetic agent while the patient is at rest;
(ii) taking one or more photographs of the patient's skin in the area treated with the cosmetic agent while the patient is performing an action;
(iii) performing digital image speckle correlation (DISC) analysis on the photographs from steps (a)(i) and (a)(ii), thereby generating a series of displacement vectors that each represents the movement of a pore from its position when the patient is at rest to its position when the patient is performing the action.
11. The method of claim 10 , wherein the method further comprises the steps of:
(b) obtaining a second degree of deformation in the area treated with the cosmetic agent comprising the steps of:
(i) taking one or more photographs of a patient's skin in the area treated with the cosmetic agent while the patient is at rest;
(ii) taking one or more photographs of the patient's skin in the area treated with the cosmetic agent while the patient is performing the action;
(iii) performing DISC analysis on the photographs from steps (b)(i) and (b)(ii), thereby generating a series of displacement vectors that each represents the movement of a pore from its position when the patient is at rest to its position when the patient is performing the action;
(c) comparing the second degree of deformation from step (b) with the first degree of deformation from step (a).
12. The method of claim 10 , wherein the area treated comprises skin of the face or neck.
13. The method of claim 12 , wherein the area to be treated comprises skin having forehead lines, glabellar lines, or crow's feet.
14. The method of claim 12 , wherein the action performed by the patient comprises smiling; moving the jaw, lips or tongue; moving the eyes; or moving the forehead.
15. The method of claim 10 , wherein the cosmetic agent that induces muscle paralysis comprises botulinum toxin.
16. The method of claim 15 , wherein the cosmetic agent that induces muscle paralysis comprises botulinum toxin type A.
17. The method of claim 10 , wherein steps (a)(i) to (a)(iii) are repeated one or more times.
18. The method of claim 11 , wherein step (b) is performed 1 week, 2 weeks, 4 weeks, 8 weeks 12 weeks, 16 weeks, 20 weeks and/or 24 weeks after the one or more injections of a cosmetic agent that induces muscle paralysis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/682,839 US20220346702A1 (en) | 2011-05-03 | 2022-02-28 | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161482057P | 2011-05-03 | 2011-05-03 | |
US13/463,766 US20130123647A1 (en) | 2011-05-03 | 2012-05-03 | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections |
US15/944,528 US11259740B2 (en) | 2011-05-03 | 2018-04-03 | Methods useful in optimizing the treatment of neuropathies and targeting tissues with cosmetic botulinum injections |
US17/682,839 US20220346702A1 (en) | 2011-05-03 | 2022-02-28 | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/944,528 Continuation US11259740B2 (en) | 2011-05-03 | 2018-04-03 | Methods useful in optimizing the treatment of neuropathies and targeting tissues with cosmetic botulinum injections |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220346702A1 true US20220346702A1 (en) | 2022-11-03 |
Family
ID=48281275
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/463,766 Abandoned US20130123647A1 (en) | 2011-05-03 | 2012-05-03 | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections |
US15/944,528 Active 2033-01-19 US11259740B2 (en) | 2011-05-03 | 2018-04-03 | Methods useful in optimizing the treatment of neuropathies and targeting tissues with cosmetic botulinum injections |
US17/682,839 Pending US20220346702A1 (en) | 2011-05-03 | 2022-02-28 | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/463,766 Abandoned US20130123647A1 (en) | 2011-05-03 | 2012-05-03 | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections |
US15/944,528 Active 2033-01-19 US11259740B2 (en) | 2011-05-03 | 2018-04-03 | Methods useful in optimizing the treatment of neuropathies and targeting tissues with cosmetic botulinum injections |
Country Status (1)
Country | Link |
---|---|
US (3) | US20130123647A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9579057B2 (en) * | 2013-12-09 | 2017-02-28 | Stefan Bradu | System for multidimensional analysis, modulation and optimization of facial expressions |
EP3017755A1 (en) | 2014-11-04 | 2016-05-11 | Samsung Electronics Co., Ltd. | Electronic device, and method for analyzing face information in electronic device |
JP6993087B2 (en) * | 2017-01-17 | 2022-02-04 | 花王株式会社 | Skin strain measurement method |
WO2018146550A1 (en) * | 2017-02-10 | 2018-08-16 | De Maio Domingos Mauricio | Methods and systems for preventing, correcting, transforming, and modifying facial, aesthetics, and consulting patients regarding the same |
CN108523842B (en) * | 2018-03-15 | 2020-12-04 | 天津大学 | Method for measuring mechanical property of human face skin |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090022665A1 (en) * | 2006-08-21 | 2009-01-22 | Afriat Isabelle | Evaluation Of Immediate-Effect Skin Molding Agents Using DISC |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5401243A (en) | 1990-08-21 | 1995-03-28 | Associated Synapse Biologics | Controlled administration of chemodenervating pharmaceuticals |
US5183462A (en) | 1990-08-21 | 1993-02-02 | Associated Synapse Biologics | Controlled administration of chemodenervating pharmaceuticals |
BR9914891A (en) | 1998-10-27 | 2001-07-17 | Mayo Foundation | Wound healing improvement processes |
US7510536B2 (en) | 1999-09-17 | 2009-03-31 | University Of Washington | Ultrasound guided high intensity focused ultrasound treatment of nerves |
PT1272204E (en) | 2000-04-14 | 2007-10-02 | Univ Pittsburgh | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
US20040220100A1 (en) | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
US7795218B2 (en) | 2001-04-12 | 2010-09-14 | Bioaxone Therapeutique Inc. | ADP-ribosyl transferase fusion variant proteins |
US7140371B2 (en) | 2002-03-14 | 2006-11-28 | Allergan, Inc. | Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins |
US6688311B2 (en) | 2002-03-14 | 2004-02-10 | Allergan, Inc. | Method for determining effect of a clostridial toxin upon a muscle |
CA2483980C (en) | 2002-04-26 | 2013-07-16 | Ian A. Ferguson | Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
US20070154529A1 (en) | 2003-01-03 | 2007-07-05 | Alcedo Biotech Gmbh | Uses of dna binding proteins |
US7687265B2 (en) | 2003-11-25 | 2010-03-30 | The General Hospital Corporation | Foxn1 and pigmentation |
US20110040171A1 (en) | 2003-12-16 | 2011-02-17 | University Of Washington | Image guided high intensity focused ultrasound treatment of nerves |
AU2005251676B2 (en) | 2004-03-03 | 2011-09-29 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
CA2857051A1 (en) | 2004-03-17 | 2005-09-29 | David Ayares | Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
US20060058238A1 (en) | 2004-09-15 | 2006-03-16 | Lee Laurent-Applegate | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
CN103356707B (en) | 2005-03-31 | 2016-07-06 | 斯丹姆涅恩有限公司 | Prepare in order to treat wound or the ulcer of diabetic neuropathy initiation, or the method for the medicine of prevention postoperative hernia formation |
US20060222634A1 (en) | 2005-03-31 | 2006-10-05 | Clarke Diana L | Amnion-derived cell compositions, methods of making and uses thereof |
US20100028306A1 (en) | 2005-03-31 | 2010-02-04 | Stemnion, Inc. | Amnion-Derived Cell Compositions, Methods of Making and Uses Thereof |
KR20200052989A (en) | 2005-12-01 | 2020-05-15 | 유니버시티 오브 메사츄세츠 로웰 | Botulinum nanoemulsions |
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
WO2007102861A2 (en) | 2005-12-02 | 2007-09-13 | Sirtris Pharmaceuticals, Inc. | Modulators of cdc2-like kinases (clks) and methods of use thereof |
US20070125390A1 (en) | 2005-12-07 | 2007-06-07 | Isabelle Afriat | Method of evaluating the effects of exogenous and endogenous factors on the skin |
WO2008039245A2 (en) | 2006-04-27 | 2008-04-03 | Anterios, Inc. | Assessment of the effects of topical administration of chemodenervating pharmaceuticals |
CN101511181B (en) | 2006-07-11 | 2013-08-21 | 新泽西医科和牙科大学 | Proteins, nucleic acids encoding the same and associated methods of use |
US9139630B2 (en) | 2006-07-11 | 2015-09-22 | Rutgers, The State University Of New Jersey | Compositions and methods for preparing recombinant MG53 and methods for optimizing same |
US10588694B1 (en) | 2007-01-19 | 2020-03-17 | Joseph Neev | Devices and methods for generation of subsurface micro-disruptions for biomedical applications |
WO2008130907A1 (en) | 2007-04-17 | 2008-10-30 | Mikos, Ltd. | System and method for using three dimensional infrared imaging to identify individuals |
US8641696B2 (en) | 2007-05-16 | 2014-02-04 | Ipsyrng Capital Development, Llc | Methods for identifying areas of a subject's skin that appear to lack volume |
US20120301444A1 (en) | 2007-09-27 | 2012-11-29 | Clarke Diana L | Amnion-derived cell compositions, methods of making and uses thereof |
US8709395B2 (en) | 2007-10-29 | 2014-04-29 | Ayman Boutros | Method for repairing or replacing damaged tissue |
US9161970B2 (en) * | 2007-12-12 | 2015-10-20 | Allergan, Inc. | Dermal filler |
US8461108B2 (en) | 2008-03-07 | 2013-06-11 | Myoscience, Inc. | Subdermal tissue remodeling using myostatin, methods and related systems |
MX2010013562A (en) | 2008-06-26 | 2011-02-15 | Anterios Inc | Dermal delivery. |
DE102008032021A1 (en) | 2008-07-07 | 2010-01-21 | Proebstle, Thomas, Dr. | A method for quantitatively analyzing the effect of an effector on muscle motility associated with muscle contraction |
US20110177025A1 (en) | 2008-07-15 | 2011-07-21 | Living Cell Products Pty Limited | Wound healing |
US10722562B2 (en) | 2008-07-23 | 2020-07-28 | Immudex Aps | Combinatorial analysis and repair |
AU2010231514A1 (en) | 2009-04-01 | 2011-11-03 | Rappaport Family Institute For Research In The Medical Sciences | A method of regulating proliferation and differentiation of keratinocytes |
WO2011038210A2 (en) | 2009-09-25 | 2011-03-31 | Curna, Inc. | Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity |
WO2011052668A1 (en) | 2009-10-28 | 2011-05-05 | 株式会社ジェノミックス | Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
CN103635198A (en) | 2010-11-12 | 2014-03-12 | 阿勒根公司 | Metabolized conditioned growth medium and methods of use |
WO2018119091A1 (en) | 2016-12-22 | 2018-06-28 | Ohio State Innovation Foundation | Compositions and methods for reprogramming somatic cells into induced vasculogenic cells |
-
2012
- 2012-05-03 US US13/463,766 patent/US20130123647A1/en not_active Abandoned
-
2018
- 2018-04-03 US US15/944,528 patent/US11259740B2/en active Active
-
2022
- 2022-02-28 US US17/682,839 patent/US20220346702A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090022665A1 (en) * | 2006-08-21 | 2009-01-22 | Afriat Isabelle | Evaluation Of Immediate-Effect Skin Molding Agents Using DISC |
Non-Patent Citations (4)
Title |
---|
Carruthers et al. 2003 PLASTIC AND RECONSTRUCTIVE SURGERY 112 Supplement 21S-30S (Year: 2003) * |
Lees 1992 BMJ London 305:1169-1170 (Year: 1992) * |
Mehta et al. 2008 Arch.Facial Plast.Surg. 10:84-87 (Year: 2008) * |
Staloff et al. 2008 Skin Res.Technol. 14:127-134 (Year: 2008) * |
Also Published As
Publication number | Publication date |
---|---|
US20180220951A1 (en) | 2018-08-09 |
US11259740B2 (en) | 2022-03-01 |
US20130123647A1 (en) | 2013-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220346702A1 (en) | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections | |
US20070125390A1 (en) | Method of evaluating the effects of exogenous and endogenous factors on the skin | |
Powers et al. | Scar assessment: current problems and future solutions | |
Chang et al. | Kinematical measure for spastic reaching in children with cerebral palsy | |
Hontanilla et al. | Automatic three-dimensional quantitative analysis for evaluation of facial movement | |
US8712512B2 (en) | Apparatus and method for exerting force on a subject tissue | |
US8200337B2 (en) | Method of selecting specific skeletal muscle highly sensitive to human psychological state, device for selecting specific skeletal muscle, method of evaluating stress during work, and system for evaluating stress during work | |
EP2563220B1 (en) | Skin profiling and its use in testing cosmetics | |
Boonipat et al. | Measuring visual attention to faces with cleft deformity | |
Wimalasena et al. | Dissecting the precise nature of itch-evoked scratching | |
Peterson et al. | Altered ventral neck muscle deformation for individuals with whiplash associated disorder compared to healthy controls–A case-control ultrasound study | |
Özsoy et al. | Three-dimensional objective evaluation of facial palsy and follow-up of recovery with a handheld scanner | |
US20080043025A1 (en) | Using DISC to Evaluate The Emotional Response Of An Individual | |
Azuma et al. | New method to evaluate sequelae of static facial asymmetry in patients with facial palsy using three-dimensional scanning analysis | |
Im et al. | Repeatability of measurements of surface electromyographic variables during maximum voluntary contraction of temporalis and masseter muscles in normal adults | |
Wolff et al. | The influence of idiopathic chronic neck pain on upper trapezius and sternocleidomastoid muscle activity and elasticity during functional reaching: A cross-sectional study | |
US20090022665A1 (en) | Evaluation Of Immediate-Effect Skin Molding Agents Using DISC | |
JP2007307294A (en) | Cosmetic evaluation system and cosmetic evaluation method | |
WO2012096081A1 (en) | Massage evaluation method, device, program and computer-readable storage medium | |
Peolsson et al. | A pilot study using Tissue Velocity Ultrasound Imaging (TVI) to assess muscle activity pattern in patients with chronic trapezius myalgia | |
Jaffer et al. | Kinematic analysis of a Duchenne smile | |
JP7288272B2 (en) | Evaluation method and evaluation device | |
Bhatnagar et al. | An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation | |
Neely et al. | Variations in maximum amplitude of facial expressions between and within normal subjects | |
Volk et al. | Objective Measurement of Outcomes inFacial Palsy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |